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Abstract
In this review, we focus on two attributes of P2X receptor channel function, one essential and one novel. First, we
propose that P2X receptors are extracellular sensors as well as receptors and ion channels. In particular, the large
extracellular domain (that comprises 70% of the molecular mass of the receptor channel protein) lends itself to be a
cellular sensor. Moreover, its exquisite sensitivity to extracellular pH, ionic strength, and multiple ligands evokes the
function of a sensor. Second, we propose that P2X receptors are extracellular zinc receptors as well as receptors for
nucleotides. We provide novel data in multiple publications and illustrative data in this invited review to suggest that zinc
triggers ATP-independent activation of P2X receptor channel function. In this light, P2X receptors are the cellular site of
integration between autocrine and paracrine zinc signaling and autocrine and paracrine purinergic signaling. P2X
receptors may sense changes in these ligands as well as in extracellular pH and ionic strength and transduce these
sensations via calcium and/or sodium entry and changes in membrane potential.
Abbreviations: ADP –adenosine diphosphate; ASIC–acid-sensing ion channels; ATP–adenosine 5¶-triphosphate; Ca
2+–
calcium; CF–cystic ﬁbrosis; CFTR–cystic ﬁbrosis transmembrane conductance regulator; Cl
j – chloride; COPD – chronic
obstructive pulmonary diseases; DEG–degenerin channels; DRASIC–ASIC from Drosophila; ENaC–epithelial Na
+
channel; FDA–US Food and Drug Administration; G protein–heterotrimeric GTP-binding protein; GPCR–G protein-
coupled receptor; H
+–proton; IP3–inositol trisphosphate; K(ATP)–ATP-regulated K
+ channel of sulfonylurea transporters
a n di n w a r d l yr e c t i f y i n gK
+ channels; K
+–potassium; MDCK–MadinYDarby canine kidney cells; Mg
2+–ma gn es iu m;
Na
+–sodium; NMDG–N-methyl-D-glucamine; OTC–over-the-counter; P2X–purinergic receptor channel subfamily;
PKD–polycystic kidney disease; PLC–phospholipase C; ppk–pickpocket from Drosophila; rpk–ripped pocket from
Drosophila; TRP–Transient receptor potential channels; ZAC–zinc-activated channel; Zip–zinc inﬂux protein trans-
porters; Zn
2+–zinc; ZnT–zinc loading or efﬂux transporter
Introduction
Our laboratory has reviewed ATP release biology recently
[1, 2]. In this mini-review and based upon Symposium and
poster presentations at Purines 2004, we wish to focus on
the idea that P2X receptor channels are extracellular
sensors for cells that express them [3, 4]. In particular,
they may be sensors for ATP, zinc, protons, and cations in
purinergic microenvironments bathing cells and occurring
within tissues where extracellular autocrine and paracrine
ATP and/or zinc signaling is critical and, arguably, most
robust. In such microenvironments, diffusion distance is
short, volume is minute, and/or ionic and pH composition
is ideal. For a P2X sensor for zinc, ATP, protons, and
cations to be relevant physiologically, these ligands must
bind to this sensor within a microenvironment, because
ATP is degraded rapidly and zinc is chelated by buffering
proteins.
Derived from the Bextracellular sensor^ hypothesis for
P2X receptor channel function, we wish to introduce the
concept that P2X receptor channels may also be viable and
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and trace element, zinc. Zinc is a well-described co-agonist
for speciﬁc P2X receptor subtypes, P2X2, P2X3, and P2X4
in particular. P2X5 and P2X6 may also bind zinc as a co-
ligand; however, the function of these two particular
subtypes has been difﬁcult to evaluate. Receptors for zinc
have been postulated for many years [3Y6]. Zinc receptors
are likely not limited to a subset of P2X receptor channels
but may also comprise a family of zinc-sensing G protein-
coupled receptors [4Y6]. Here, we highlight recent pub-
lished evidence that zinc is a full agonist for epithelial
P2X receptors independent of ATP [4, 7]. We also have
published evidence that extracellular zinc alone can
mobilize Ca
2+ release from intracellular stores [4], suggest-
ing a second type of zinc membrane receptor coupled to
intracellular signaling effectors. We hope that this review
will shed light on a new sub-ﬁeld of extracellular pu-
rinergic signaling that integrates with a rapidly emerging
ﬁeld of extracellular zinc signaling.
A new view of P2X receptor channels
as extracellular sensors
The family of P2X receptor channels and their properties
was reviewed elegantly and recently by North [8]. We do
not wish to be repetitive to this seminal contribution.
Rather, we wish to focus on the idea that the large
extracellular domain for P2X receptors acts as a sensor
on the cell surface for multiple and different extracellular
substances. This extracellular domain comprises approxi-
mately 70% of the molecular mass of P2X receptor channel
proteins. This extracellular domain provides the binding
pocket for the nucleotide as well as a binding site or sites
for zinc. In P2X2 through P2X4 (and, possibly, for P2X6),
zinc acts as an agonist [8]. In P2X1 and P2X7, zinc is an
antagonist [8]. Extracellular pH also governs P2X receptor
function [8]. As such, there are thought to be one or more
sites for proton (H
+) binding within the extracellular
domain of the receptor channel [8]. We hypothesize
currently that external pH may govern zinc and ATP
binding to the extracellular domain. As a cation-permeable
channel, multiple binding sites for calcium (Ca
2+) and
sodium (Na
+) likely also exist to facilitate cation perme-
ation through the extracellular domain and the channel
pore [8]. With multiple binding sites for so many different
extracellular constituents, the P2X receptor extracellular
domain will be fascinating to visualize in the coming years
when a crystal structure emerges.
Meanwhile, our laboratory continues to draw topological
analogies between P2X receptor channels and the degen-
erins (DEG)/epithelial Na
+ channel or ENaC superfamily
[1, 8Y13]. The ENaC superfamily includes the ENaC gene
family, the degenerin genes/proteins from C. elegans, the
ripped pocket (rpk) and pickpocket (ppk) genes/proteins
from Drosophila, the acid-sensing ion channels (ASICs,
DRASIC), and the brain NaC channels (BNaCs) [8Y13].
Despite the fact that there is no nucleotide or amino acid
sequence homology, they possess a topology similar to
P2XRs (see Figure 1 below). In particular, each family has
a large extracellular domain that represents 70% of the
molecular mass of the polypeptide. All P2XRs, ENaCs,
and ENaC relatives possess an even number of extracellu-
lar cysteine residues that may participate in similar intra-
chain disulﬁde bonding to provide critical three-dimen-
sional structure to this domain. For example, all subunits of
ENaCs, a-, b-, g-, and d-ENaC, have 14 conserved cys-
teines in their extracellular domain and all ASIC subtypes
have 12 conserved cysteines. Each P2XR subtype has 10.
The even number of conserved cysteines suggests that all
extracellular cysteines may participate in intrachain disul-
ﬁde bonding and confer an elaborate three-dimensional
structure on the extracellular domain.
However, they could also participate in zinc binding
under certain conditions. Indeed, histidines and cysteines
comprise zinc-binding domains in zinc ﬁngers and other
related domains. Although analysis by our laboratory indi-
cates that bona ﬁde zinc ﬁngers are not present in P2XRs,
histidines cluster within the cysteine-rich regions of P2XR
extracellular domains and may collaborate to confer a zinc
ﬁnger-like binding domain, especially in a three-dimen-
sional manner not yet visualized. Recent work by Ennion
and Evans indicated that all 10 cysteine residues in the
extracellular loop of the P2X1 receptor are thought to
participate in disulﬁde bridging [14]. Five disulﬁde bonds
were formed. C117-C165, C126-C149, and C132-C159
were formed in the ﬁrst cysteine-rich region, while C217-
227 and C261-C270 were formed in the second cysteine-
rich region [14]. They also indicated that none of these
bonds are individually essential for channel function, but
the disruption of the C261-C270 bond and C117-C165
bond affected trafﬁcking to the plasma membrane. The
Figure 1. Cartoon of the topology of P2XRs and cation channels of the
ENaC superfamily. P2XRs are a member of the two transmembrane-
spanning cation channel superfamily that includes amiloride-sensitive
ENaC sodium channels and ENaC relatives in neurons (BNaCs, ASICs,
DEGs, RPK, and PPK). Below the cartoons are listed the demonstrated or
postulated sensory roles for these related cation channels within this
superfamily.
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P2X2 by Hume and colleagues [15]. They also found
evidence for disulﬁde bridges between pairs of cysteine
residues that are conserved between P2X1,P 2 X 2, and all
other subtypes. They also saw some effects on zinc poten-
tiation, suggesting that cysteines might contribute structure
to a zinc binding site [15]. They also could not assign all
cysteines to disulﬁde bridges, suggesting that some may be
free to participate in other reactions. A more recent paper
by Hume and coworkers showed that zinc binding may
involve cysteines across separate subunits within a multi-
mer [16]. As such, the zinc binding site may lie within a
pocket contributed by multiple extracellular domains
within a multimer [16]. Taken together, this disulﬁde
bridging could be dynamic, freeing up these residues for
zinc binding under certain conditions. Proper topology and
glycosylation of the P2XRs may indeed be critical for
proper ER processing and trafﬁcking through the secretory
pathway. Examination of extracellular domain cysteines
and histidines clustered within the cysteine-rich regions
will be critical to assess zinc binding to speciﬁc P2XRs in
the coming years.
The same can be postulated for the ENaC superfamily,
although the exact nature of the intra-chain disulﬁde bond-
ing between extracellular cysteines may differ and the three-
dimensional structure may as well. However, the concept
of the ENaC superfamily as extracellular sensors has
been postulated. Extracellular protons (H
+) gate the ASICs
[17]. Their name, the acid-sensing ion channels, was well
thought [17]. Lazdunski and colleagues have shown ele-
gantly that zinc can potentiate acid gating of the ASICs
[17]. Extracellular H
+ and zinc also synergistically poten-
tiate BNaC function [18, 19]. Recent studies by Driscoll’s
group has shown that some of the degenerin channels are
permeable to calcium [20], making them putative calcium
entry channels in the worm. Extracellular H
+ and acidic
external pH activate the most recently cloned ENaC sub-
unit, d-ENaC [21]. Human d-ENaC is potentiated dramat-
ically in its function at pH 5.0. A mouse ortholog has not
bee found yet; however, this subunit may confer acid sens-
ing upon ENaC heteromultimers in certain microenviron-
ments. Taken together, these seminal papers and reviews
have shed light on this DEG/ENaC superfamily as being
critically involved in touch, temperature, mechanical, pH
and other sensory mechanisms. It is likely that they are
sensors too.
Members of the ENaC superfamily have been implicated
as mechanical sensors, especially ENaC relatives in C.
elegans and Drosophila [9Y13]. ENaC itself as well and the
DEG channels have been shown to be modulated by
membrane stretch by Benos and colleagues among others
[22Y25]. Although zinc is a ligand for some members of
the ENaC superfamily, a bona ﬁde endogenous ligand for
members of the ENaC superfamily remains elusive. Our
laboratory hypothesizes that ENaC and ENaC relatives
likely bind an endogenous ligand that has yet to be eluci-
dated. A current cartoon of P2XRs, ENaC, mammalian
ENaC relatives, and ENaC relatives from the worm and the
ﬂy are shown in Figure 1, along with current opinion and
hypotheses about the sensory function of these two trans-
membrane-spanning cation channels within this unique
extracellular domain.
Epithelial P2X receptors are sensors for ATP, zinc,
and cations
Recent work performed by our laboratory suggests that
P2X receptor Ca
2+ entry channel function is markedly sen-
sitive to changes in external H
+ and Na
+ concentration and
is gated by zinc alone, ATP alone, or both. A combina-
tion of zinc and ATP in micromolar concentrations poten-
tiates Ca
2+ entry through epithelial P2X receptor channels
[3, 4, 7]. The combination of ligands likely is optimal for
Figure 2. Epithelial P2X4 and P2X6 are the subtypes that are likely stimulated by zinc in our experimental conditions. Extracellular histidines are
shown for the three subtypes shown to be expressed in epithelia at the mRNA and protein level. We believe that an alkaline pH deprotonates these
histidines allowing zinc to bind with higher afﬁnity. We also believe that removal of Na
+ abolishes its competition with Ca
2+ for the channel pore and
that it also unmasks histidines within the cysteine-rich domains for better zinc binding.
P2X receptor channels are zinc and ATP sensors 301gating of P2X receptor channel activity. RNA and protein
expression studies in epithelial and endothelial cell models
from many different tissues showed shared expression of
P2X4, P2X5, and P2X6.These critical epithelial and en-
dothelial P2XR subtypes are illustrated in Figure 2 with the
sites of cysteines reﬂected by putative disulﬁde bridges and
the sites of histidines shown. More recent siRNA analysis
showed recently that P2X4 and P2X6 collaborate to confer
extracellular zinc-induced Ca
2+ entry independent of P2X5.
We have not ruled out the possibility that P2X5 may confer
ligand-induced effects on a heteromultimeric complex of
epithelial P2X receptor channels without conducting Ca
2+
itself. P2X receptor subtypes are known to form homomul-
timers or heteromultimers [8, 26, 27]. With the exception
of P2X6 that may [28] or may not [8] form a receptor
channel by itself, all other P2XR subtypes can co-assemble
into homomultimers. Known heteromultimers include
P2X1/5, P2X2/3,P 2 X 2/6 and P2X4/6 [8]. Other heteromul-
timers are likely to emerge [5]. It is important to note that
P2X6 is an important modulatory subtype for other P2X
receptor subtypes. Nevertheless, recently, glycosylated
P2X6 was shown to form a high afﬁnity ATP-gated cation
channel, while non-glycosylated P2X6 does not [28]. We
now hypothesize that it plays a special modulatory role for
P2X4 in airway and other epithelial cell biology. We intend
to focus on the role of these wild-type epithelial P2X
receptor channel subtypes in the coming years.
This P2X receptor-mediated Ca
2+ entry in airway and
other epithelia is more optimal when the extracellular
saline or Ringers is modiﬁed to dysinhibit Ca
2+ movement
through the Ca
2+-permeable non-selective cation channel
pore of P2X purinergic receptor channels. Most Ca
2+ entry
channels are, by deﬁnition, Ca
2+-permeable non-selective
cation channels that mediate Na
+ inﬂux as well as Ca
2+
entry down a favorable chemical concentration gradient
into the cell [29Y33]. Despite a favorable permeability ratio
for Ca
2+ over Na
+,N a
+ is 140 mM in normal Ringer or
plasma while Ca
2+ is 1Y2m M .N a
+ will, thus, always win
this competition with Ca
2+. Potassium (K
+) can move in
the opposite direction (e.g., out of the cell) down its favor-
able gradient through P2X receptor channels. This perme-
ability of P2X receptor channels may also have critical
physiological implications that are yet to be appreciated.
When we replaced Na
+ with an impermeant cation in the
extracellular saline vehicle such as N-methyl-D-glucamine
(NMDG) or Tris, the sustained nature or Fplateau_ of the
Ca
2+ entry signal triggered by zinc and ATP was aug-
mented in human airway epithelial cells [3, 4, 7]. Figure 3
shows the effect of combining all of these modiﬁcations of
the Ca
2+ signal in original data not included in our recent
publication [4]. The same effects have been observed in
model epithelia as well as non-epithelial cell models from
other tissues (EM Schwiebert, unpublished observations).
Modulation of H
+ concentration or pH in the extracellular
saline vehicle was also crucial to the magnitude and sus-
tained nature of the epithelial P2X receptor-mediated Ca
2+
entry signal (Figure 3A). While most P2X receptor
subtypes are stimulated or inhibited by external acidic
pH, epithelial P2X receptor stimulation by extracellular
zinc and ATP was potentiated markedly by a mild external
alkaline pH of 7.9. External pH values of 7.9 or higher
potentiated zinc and ATP gating of P2X receptor Ca
2+
entry channels markedly in airway epithelia. We postulate
currently that external Na
+ and H
+ concentrations govern
zinc and ATP binding to the extracellular domain of these
epithelial P2X receptors. It is important to note that these
saline vehicle conditions can be modiﬁed in the context of
therapies for cystic ﬁbrosis (CF) and other respiratory
disorders where the agonists can be sprayed, nebulized or
aerosolized in that modiﬁed vehicle. They could also be
modiﬁed in topical solutions applied to the skin, eye, ear,
etc. Therapeutic angles involving the targeting of zinc or
zinc plus ATP to P2X receptors are addressed below.
The P2X receptor channel is not just an ATP
receptor anymore
P2X receptors are zinc receptors
Our laboratory is exploiting the ability of the P2X receptor
channel to bind zinc as a full agonist for possible
therapeutic importance in cystic ﬁbrosis (CF) and other
diseases. Sustained Ca
2+ entry mediated by epithelial P2X
receptor channels and stimulated by zinc and ATP was also
mimicked by addition of zinc alone. In addition to the
robust and sustained Ca
2+ entry signal alluded to above,
Figure 3A also shows the experiment that made us realize
that the P2X receptor channel may be a zinc receptor. In an
error in solution switching, ATP was washed away ﬁrst
instead of zinc. The sustained Ca
2+ signal continued
unabated in the presence of zinc alone. In Figure 3B, we
show the sustained Ca
2+ signal elicited with zinc alone in
the presence of extracellular Ca
2+. It is important to note
that, in this and previous studies, all other possible routes
of Ca
2+ entry were ruled out through experimentation or
from the literature [3, 4]. In Figure 3C, we show that zinc
alone triggered a Ca
2+ release from intracellular stores. We
hypothesize currently that the sustained Ca
2+ plateau or
signal induced by extracellular zinc alone is a combination
of opening epithelial P2X receptor channels and engaging
zinc-sensing G protein-coupled receptors. Study of these
dual zinc receptors in epithelial and other cell models is in
progress.
Nevertheless, we wanted to conﬁrm that this was a zinc
effect independent of the nucleotide on epithelial P2X
receptor channels. We were well aware of ﬂow- and
mechanically induced ATP release and that it may be
occurring in our ﬂow-based ﬂuorescence imaging system
[3, 4, 7]. Further analysis of this zinc effect within a
perfused ﬂuorimeter system monitoring Fura-2/AM ﬂuores-
cence showed that endogenous release of ATP was
potentiating zinceffects.InFigure 3D,complete elimination
of ATP and ADP with the ATP scavengers, hexokinase and
apyrase, reduced but did not prevent zinc from triggering a
robust and sustained Ca
2+ entry signal (Figure 3D). The
average increase in cell Ca
2+ triggered by this dose of zinc
salt is shown by the dashed line superimposed on this
302 E.M. Schwiebert et al.Figure 3. Potentiation of Ca
2+ entry mediated by P2X receptor channels by zinc alone. Conﬂuent IB3-1 cystic ﬁbrosis human airway epithelial cells
grown on coverslips and inserted into a perfused cuvette within a ﬂuorimeter were used for these experiments. Fluorescence from the entire conﬂuent
culture was measured. The effects of extracellular zinc are reproducible and consistent. The perfusion began with a standard Na-containing ringer. We
then switched to a BCa
2+ entry Ringer^ where Na was replaced with N-methyl-D-glucamine (NMDG), pH was modiﬁed to 7.9, [Ca
2+] was increased to
3 mM, and Mg
2+ was omitted. Because these zinc receptors and responses on intact in CF airways cells and translate into rescue of Cl
j secretion, we
postulate that this is a viable signaling pathway to target with putative zinc-based therapeutic formulations. (A) This plot shows the key experimenti n
which ATP (100 mM) was removed ﬁrst in a way that was not intended. Zinc (20 mM) remained in the perfusate and the sustained Ca
2+ entry signal
remained. Removal of zinc from the perfusate reversed the Ca
2+ entry signal back to baseline, showing complete reversibility of zinc effects. (B)
Because of this unexpected result from this unintended experiment (we had intended to remove zinc ﬁrst in A), we assessed the effects of zinc alone in
the perfusate independent of exogenously added ATP. Zinc elicited the same Ca
2+ entry signal. In this case, zinc remained in the perfusate but we
omitted Ca
2+ from the solution and the Ca
2+ entry signal was reversed completely. (C) Although the experiment in B suggested that extracellular zinc
alone triggered marked Ca
2+ entry from extracellular stores, we performed the requisite experiment of assessing zinc effects in the absence of
extracellular Ca
2+. To our surprise, extracellular zinc alone triggered a Ca
2+ release from intracellular stores that was transient and reminiscent of
thapsigargin-induced release from ER stores. (D) Despite the compelling results with zinc alone, we were aware that the ﬂow of the perfusate might
induce release of endogenous ATP into the system. As such, we assessed the effects of zinc in the presence of dual ATP scavengers, hexokinase (5 U/ml
with 5 mM glucose) and apyrase (1 U/ml). The response to zinc was reduced but not eliminated, suggesting ATP-independent effects of zinc. (E) To
quantify precisely the [ATP] concentration achieved by ﬂow-induced release of endogenous ATP, we captured the perfusate under Fno ﬂow_ and
Bstandard ﬂow rate^ conditions. Flow induced a release of ATP from the cells that was approximately 1 mM. Presence of either scavenger or both
scavengers at the concentrations used eliminated circulating ATP from the system to a level at or below 1 nM near the lower limit of detection with
luciferase and luciferin-based methods [100]. Please note the dramatically different Y-axis scales with regard to [ATP] between these graphs.
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ATP released in these perfused ﬂuorimetry measurements
within the cuvette that holds the conﬂuent coverslip of CF
human airway epithelial cells, we captured the solution in
the cuvette in the absence of ﬂow and the Fﬂow-through_ at
the standard perfusion rate used in our ﬂuorescence studies.
Interestingly, this ﬂow stimulus augmented ATP release
markedly to an estimated ATP concentration of slightly
above 1 mM (Figure 3E). Sampling in the presence of
either hexokinase or apyrase at the concentrations used in
the experiment with zinc in Figure 3D revealed a complete
elimination of ATP in the system. Presence of both
scavengers did the same. Values of released ATP in the
presence of one or both scavengers were less that 1 nM
which is pushing the sensitivity of detection by luciferase/
luciferin-based methods. Taken together, these data and
previous ﬁndings strongly suggest that zinc can engage and
stimulate P2X receptors in an ATP-independent manner.
We also postulate currently that zinc binding to the
extracellular domain may increase the afﬁnity of the
extracellular domain for ATP to allow ATP to engage the
receptor at a much lower dose. Nevertheless, our ﬁndings
suggest that the biometal does not require ATP to engage
the P2X receptor and open its channel.
A second zinc receptor?
Moreover, our data also revealed that zinc could trigger a
Ca
2+ transient derived from intracellular stores in the
absence of extracellular Ca
2+ (Figure 3C above). This
Ca
2+ transient induced by zinc in 0 Ca
2+ solutions was
abolished by thapsigargin pretreatment and emptying of
intracellular stores [4], suggesting that zinc may also
engage a cell surface zinc receptor coupled to intracellular
signal transduction effectors. Such a zinc-sensing G
protein-coupled receptor has been postulated for colono-
cytes and hepatocytes [5, 6]. We are intrigued that such a
receptor is also expressed in airway epithelia. We have not
ruled out the possibility that extracellular zinc could
engage calcium-sensing G protein-coupled receptors [34].
Such a possibility may be unlikely due to recent work
showing that cadmium, zinc, and nickel engage a divalent
cation sensing receptor with properties distinct from the
calcium-sensing receptor [34]. This divalent cation-sensing
receptor was found to be coupled to phospholipase C
(PLC) and inositol trisphosphate (IP3) [34]. A second
divalent cation-sensing and Ca
2+-mobilizing receptor
mechanism triggered by zinc could also contribute to the
sustained nature of the zinc-induced Ca
2+ signal observed
in airway epithelia. We also believe that zinc may enter the
cell through zinc-speciﬁc transporters and modulate Ca
2+
buffering mechanisms to potentiate the Ca
2+ signal. One
study suggests that intracellular Zn
2+ inhibits plasma
membrane Ca
2+ ATPase pumps in a membrane vesicle
preparation [35]. Nevertheless, removal of zinc leads to a
complete reversal of the sustained Ca
2+ plateau to baseline.
Therefore, zinc does not affect all of the buffering
mechanisms in the cell. This concept is addressed below
in terms of therapeutic angles for zinc-based formulations.
We have reviewed past literature to determine whether
P2X receptor channels were ever studied as biometal
receptors independent of the nucleotide ligand. Although
we have found a plethora of studies including assessment
of copper and zinc competition as co-agonists [8, 36], ATP
or an ATP analog was always included in these and other
experiments as the primary agonist. We currently view
P2X receptors as zinc receptors and ATP receptors where
each ligand can engage the receptor and open the channel
independently as well as together. Indeed, the recent study
deﬁning an intrasubunit binding site for zinc among
multiple P2X2 receptor subunits [16] is compelling and
supports our case as well as that of others.
Exploiting the sensor properties and zinc gating of P2X
receptor channels for putative therapies
Cystic ﬁbrosis and other respiratory diseases
Until now, therapeutic approaches with Ca
2+ mobilizing
agonists in CF have only yielded a transient increase in
cytosolic free Ca
2+ and a transient rescue of chloride (Cl
j)
permeability or Cl
j secretion [37, 38]. Transient effects
are insufﬁcient in CF, because CFTR Cl
j channels in non-
CF tissues are stimulated in a monophasic and sustained
manner by cyclic nucleotides. As such, a therapeutic
approach targeted at a naturally expressed receptor or
channel must have a sustained effect. Moreover, this effect
should also be reversible and re-acquirable (i.e., should
show reversal and not show tachyphylaxis or inactivation).
When we achieved a sustained Ca
2+ signal with zinc alone
or with zinc and ATP that ranged from 200 to 600 nM
above baseline in both non-CF and CF human airway
epithelial cell models, we hypothesized that we could
translate this sustained signal into a sustained rescue of Cl
j
permeability in CF that rivaled CFTR activation in a
normal cell. Such a sustained and marked Ca
2+ signal was
already shown to potentiate ciliary beat [39Y41].
In two CF mouse models (and in another since), we
achieved a sustained rescue of Cl
j secretion in our FCa
2+
entry Ringer_ that was equivalent to or greater than that
achieved by stimulation of CFTR Cl
j channels by
albuterol and adenosine, two complementary cyclic AMP
mobilizing agonists [4]. Cl
j permeability rescue was
assessed in non-polarized CF human airway epithelial cells
by an SPQ halide ﬂuorescence assay in vitro, in polarized
CF human and mouse airways epithelial cells in Ussing
chambers in vitro, and in CF mouse nasal mucosa by an
in vivo nasal potential difference assay [4]. We are
currently deﬁning any and all apical conductances that we
may be stimulating with this sustained Ca
2+ entry approach
to rescue Cl
j permeability and Cl
j and water secretion.
The proposed cellular mechanism of this rescue is shown
in Figure 4.
The beneﬁts of extracellular zinc and zinc-induced Ca
2+
entry via P2X receptor channels may not be limited to
rescue of Cl
j secretion. Potentiation of ciliary beat can
only help in CF. Moreover, extracellular zinc may inhibit
304 E.M. Schwiebert et al.hyperactive ENaC channel-mediated hyperabsorption of
sodium directly (42 and D Olteanu, A Zsembery, and EM
Schwiebert, unpublished observations). It is important to
note that these data derived from epithelial cell systems
differ from data garnered by Kleyman and coworkers in
Xenopus oocytes overexpressing ENaC heteromultimers
[43Y45]. We believe that these are very different systems.
There is also disagreement within the Xenopus oocyte
system, where Van Driessche and coworkers ﬁnd zinc
inhibition [42, 46] and Kleyman and colleagues ﬁnd zinc
potentiation by removal of Na
+ self-inhibition [43Y45]. Or,
the increase in cell Ca
2+ mediated by P2X receptors should
attenuate upregulated ENaC in CF [9, 10, 20]. This sus-
tained Ca
2+ signal would also open Ca
2+ activated K
+
channels that would augment Cl
j secretion electrically in
either or both membranes [47Y52]. We are investigating
these additional cellular mechanisms of possible therapeu-
tic beneﬁt for CF that could involve zinc-based formula-
tions. These cellular mechanisms are also listed and/or
shown in Figure 4.
Zinc is a cytoprotective biometal and a well-known anti-
inﬂammatory [53, 54]. Despite this known fact, the cellular
and molecular mechanisms of action are ill-deﬁned. Zinc
salts are formulated within wound healing and skin creams
and solutions as topical over-the-counter (OTC) homeo-
pathic (5Y10% zinc salt formulations) and FDA-approved
medicines (0.1Y0.25% zinc salt formulations) [55]. Zinc
salts also have anti-viral and anti-bacterial properties
[56Y58]. Oral zinc supplementation of nutrition and diet
has led to a reduction in the incidence and severity of
multiple infectious diseases [59, 60]. Zinc salts also have
anti-oxidant and anti-apoptotic properties [61]. The cellular
and molecular mechanisms of these effects are only
beginning to emerge. Figure 5 extends our hypotheses of
these additional possible beneﬁts of zinc action for CF
therapy. CF also has upregulated neutrophil activation and
transmigration and presents with chronic and recurrent
bacterial infections [62]. As such, a zinc-based formulation
might be therapeutic against these CF endpoints as well as
a multitude of other respiratory diseases that include com-
Figure 5. Cellular mechanisms of zinc’s anti-inﬂammatory effects in epithelial cells and other cells? Zinc interactions with membrane receptors may
have anti-inﬂammatory beneﬁts. However, if zinc could gain entry into airway epithelia, it is then free to bind to any and all enzymes that require it as a
co-factor. Many effectors within inﬂammatory signaling cascades have zinc ﬁnger motifs. If zinc binding has a net inhibitory effect, then inﬂammatory
signaling could be attenuated.
Figure 4. Possible therapeutic beneﬁts of zinc-based fourmations for
cystic ﬁbrosis. Possible beneﬁts of zinc are listed. Multiple CF defects
could beneﬁt by zinc binding to P2X receptor channels on or from zinc
entry into CF human airway epithelial cells (see Figure 6 for postulated
beneﬁts of zinc entry). An increase in Ca
2+ induced by zinc at P2X
receptor or possible direct zinc inhibition would disable hyperactive ENaC
channels. The sustained Ca
2+ entry signal mediated by P2X receptor
channels would require KCl secretion and augment ciliary beat. The latter
is not affected in CF; however, augmentation of ciliary beat can only help
clear tenacious and dehydrated mucus.
P2X receptor channels are zinc and ATP sensors 305mon cold, asthma, allergy, and chronic obstructive pulmo-
nary diseases (COPD). Interestingly, a large percentage of
CF patients have zinc deﬁciency due to malabsorption or,
perhaps, other etiologies [63, 64]. Zinc could be anti-
inﬂammatory via interactions with multiple receptor sub-
types (Figure 5).
Alternatively, if zinc could gain entry into cells, it might
affect signaling effector molecules directly (Figure 5).
Such entry could occur through Zip inﬂux transporters that
speciﬁcally transport zinc into cells [65Y67]. Many such
effector molecules have zinc ﬁnger binding motifs. A
recent review by Zalewski and colleagues also sheds much
light on the biological importance and therapeutic potential
of zinc in the lung and airways [68]. They show evidence
that labile zinc (that not bound by buffering proteins or
enzymes and other proteins for which it serves as a cofac-
tor) is often absorbed by cells and packaged in vesicles
(especially, secretory granules) where it may be exocy-
tosed [68]. They estimate that high nanomolar to low mi-
cromolar zinc could be present in extracellular ﬂuids under
certain physiological conditions, secreted as an agonist
itself or co-secreted with other ligands or hormones [68].
We hypothesize currently that zinc may attenuate induction
of key inﬂammatory transcription factors and apoptotic
effector proteins by gaining entry into epithelial and other
cells. We also hypothesize that zinc itself is an important
autocrine and paracrine ligand in the lung and airways and
elsewhere (see below). It is our sincere hope that zinc-
based therapeutic formulations will emerge in the near
future to help ﬁght CF and other respiratory diseases.
Despite the lack of understanding with regard to cellular
mechanisms of action, however, zinc salts are being formu-
lated in over 10 over-the-counter homeopathic medicines
to ﬁght common cold by a multitude of OTC remedy manu-
facturers [69Y71]. The concentrations of zinc salt in these
remedies are quite high and may cause harm to olfaction
and gustation [72, 73]. We intend to restrict our putative
therapeutic doses in the micromolar range because of these
potentially harmful effects. The zinc OTC homeopathics
have a range of doses from 5 to 10% zinc salt which
translates into a molar concentration range of 16Y50 mM
zinc salt. It is not clear why such a high dose is used or if it
is even necessary.
Polycystic kidney disease
We have adopted a similar approach to another prevalent
geneticdisease,polycystic kidneydisease (orPKD).For this
disease and for a a family of Bfailure to secrete^ endocrine
disorders such as diabetes, an oral delivery of zinc salts may
be warranted and this is FDA-approved at signiﬁcant doses
for the copper chelating disorder, Wilson’s disease [74Y77].
A more direct delivery method could also be contemplated.
Figure 6 illustrates a common thread that occurs in both
genetic forms of PKD. A galvanizing feature of the ﬁeld is
the fact that protein products of genes implicated in mouse
models and human forms of the diseases cluster on or at
the apical central monocilium of ductal epithelia [78Y80].
The collecting duct of the nephron is a common site for
both genetic forms of PKD, autosomal dominant and auto-
somal recessive. This organelle was thought to have little
function besides a morphological feature that deﬁned one
ductal epithelial cell type versus another [81]. However,
Figure 6. Finding alternative Ca
2+ entry mechanisms in ductal epithelia afﬂicted with polycystic kidney disease: A possible therapeutic beneﬁt? In both
genetic forms of PKD, proteins affected by mutation appear to cluster in the apical central monocilium in renal collecting duct epithelia and in ductal
epithelia from other tissues. In mouse and human forms of PKD, this cilium is deﬁcient (either abnormal in function or malformed). Apical monocilia
have been shown to mediate touch- or ﬂow-induced Ca
2+ entry. The latter would be a physiological stimulus for the collecting duct, where tubular ﬂuid
ﬂows over it continually. In the absence of a competent monocilium, opening of an alternative Ca
2+ entry channel or pathway could recover this cilium-
speciﬁc Ca
2+ signaling.
306 E.M. Schwiebert et al.recent work has shown that this organelle, which extends
well out beyond the unstirred layer of a duct or tubule, may
have sensory functions [82Y84]. Principal among these
functions is a mechanosensory role [82Y86]. Touch or ﬂow
across this monocilium in MadinYDarby canine kidney
(MDCK) cells triggered a Ca
2+ transient that led to a Ca
2+
wave within the monolayer of cells [82]. The Ca
2+ entry
channel involved is likely polycystin-2, a PKD gene pro-
duct that is a distant member of the transient receptor po-
tential (TRP) Ca
2+ entry channel superfamily [87, 88].
Roles for additional TRP channels in this monocilium-
derived Ca
2+ entry have not been ruled out [89, 90]. It is
also possible that the apical or luminal monocilium may
also be an osmosensor or a chemosensor for ductal epi-
thelia. Epithelial cells along the duct may need to sense
ﬂow as well as sample the ﬂuid ﬂowing through the tubule
or duct to ascertain whether the ﬂuids produced are of
normal composition.
Figure 6 compares a cilium-competent ductal epithelial
cell from the cortical collecting duct of the kidney with a
cilium-deﬁcient cell. In the renal collecting duct, the
principal cell is the major monociliated cell [81]. In a
cilium-deﬁcient cell, cilium-derived Ca
2+ signaling is lost.
In the face of this and likely other signaling defects, Na
+
absorption appears upregulated in cilium-deﬁcient princi-
pal cells ([91] and D. Olteanu, B.K. Yoder and E.M.
Schwiebert, unpublished observations). Because ENaC
channels are tonically active, loss of an inhibitory signal
may leave them dysinhibited. Moreover, chronic Ca
2+
entry signals may also support many other ductal epithelial
cell functions. As such, to curtail hypertension and to
correct the lost Ca
2+ entry signal, alternative Ca
2+ entry
channels or pathways must be sought. Figure 6 also shows
multiple possible targets for this therapeutic angle.
Principal among those are epithelial P2X receptor chan-
nels. The collecting duct luminal chemical microenviron-
ment would be ideal for extracellular zinc and ATP binding
and Ca
2+ entry, because Na
+ and Mg
2+ are almost
completely reabsorbed from the tubular ﬂuid (5% or less
is left for each cation). As such, our Ca
2+ entry Ringer is a
close approximation to collecting duct tubular ﬂuid [3, 4,
7], particularly with regard to Na
+ and Mg
2+ concentra-
tions. Both extracellular ligands, zinc and ATP, are freely
ﬁltered at the glomerulus and may also be released by ﬂow
and other stimuli along the nephron. We hope and believe
that this may be a viable primary or adjunct therapy along
with administration of the diuretic, amiloride, and the
aldosterone antagonist, spironolactone, to ﬁght hyperten-
sion in PKD [92] and other renal hypertensive disorders.
B Failure to secrete^ endocrine and neuroendocrine
disorders
Ca
2+ entry is an essential trigger for exocytosis in all cells.
Ca
2+ release from intracellular stores is insufﬁcient,
especially in immune, endocrine or neuroendocrine cells
that function mainly as secretory cells. Secretory cells, in
this case, are those whose major function is to release
agonist. Figure 7 shows the normal components that are
involved in stimulusYsecretion coupling in the pancreatic
bcellintheisletsofLangarhans [93Y95]. Normally, glucose
rises in the plasma after a meal. It is taken up by b cells
where it triggers new intracellular ATP synthesis. When
the ATP/ADP ratio rises, ATP overcomes ADP and
inhibits the K(ATP) channel complex. Closure of these
tonically active K
+ channels depolarizes the cell. The b cell
is an excitable cell, despite the fact it is not morphol-
ogically akin to nerve or muscle cells. Voltage-dependent
Ca
2+ entry channels open in response to the depolarizing
Figure 7. Control of hyperglycemic diabetic syndromes with a zinc-based therapeutic formulation? In the controlled diabetic scenario, by-passing the
glucose- and voltage-dependent mechanism of Ca
2+ entry and insulin secretion by activating an alternative Ca
2+ entry channel pathway (CaEC) could be
an important therapeutic modality in diabetes and could re-stimulate insulin secretion. P2XR receptor Ca
2+ entry channel may be such a pathway. Such
an approach only requires the Ca
2+ entry step that would trigger the exocytosis of secretory granules containing insulin, ATP, and zinc. We are interested
in the autocrine effects of all three secreted agonists for normal b cell physiology. Zinc may also be a cytoprotective for the diabetic b cell that is targeted
for autoimmune desctruction or some other cellular stress in multiple diabetic states.
P2X receptor channels are zinc and ATP sensors 307membrane potential. This glucose- and voltage-dependent
Ca
2+ entry triggers the fusion and release of the contents of
insulin secretory granules.
In multiple diabetic and/or hyperglycemic states, pan-
creatic b cells are disabled in their ability to secrete insulin
[96] or are reduced in mass and number in the face of
autoimmune (type I) or type 2 diabetes-speciﬁc insults
[96]. Any maneuver to rescue impaired insulin secretion or
to maximize the function of remaining b cells or trans-
planted b cells in destructive diabetic states might prove
helpful to diabetics. Figure 7 also shows these hypothe-
sized therapeutic angles. First, in terms of glucose- and
voltage-independent rescue of insulin secretion, a prime
target for an alternative Ca
2+ entry pathway that is
sustained and robust is the extracellular zinc and ATP-
gated P2X receptor channel. We ﬁrst thought that this
translational physiology might be far-fetched. In reality, an
explosion of recent papers has examined zinc deﬁciency in
numerous diabetic and hyperglycemic states [97]. Nutri-
tional experts are examining the importance of adequate
zinc intake in gestational diabetes and other forms of
diabetes relating to acquired insulin resistance [97].
Moreover, zinc biology is closely coupled to insulin
biology. Every commercially available insulin injection
for a diabetic has millimolar zinc salt included with the
puriﬁed insulin polypeptide [55]. Zinc is an essential
cofactor for insulin packaging within the secretory granule
and insulin multimerization (hexamerization) within the
secretory granule [97].
Within the b cell, zinc is loaded and packaged with in-
sulin. A particular zinc-speciﬁc transporter, ZnT8, is only
expressed in b cells within the pancreatic islet where it
loads the insulin-containing secretory granule with this
essential cofactor [98]. As such, zinc must be co-released
with insulin. The same has been suggested for insulin and
ATP [99]. As such, once insulin is released, millimolar
quanta of zinc and ATP also appear extracellularly. Al-
though the concentration of each will dilute in the inter-
stitium, we hypothesize that extracellular zinc and ATP are
key autocrine and paracrine mediators for the b cell in
particular and the islet in general. Binding of either or both
to P2X receptor channels may potentiate insulin release in
the short term. Extracellular zinc may also be absorbed into
the b cell cytosol via Zip zinc-speciﬁc inﬂux transporters.
We speculate that zinc may be cytoprotective for the b cell
in the cytosol and protect it from autoimmune-, oxidative-,
or circulating factor-mediated destruction. This b cell
biology is a new focus of our laboratory.
Future directions
We hope that these data, ideas, and interpretations of the
literature spawn new sub-ﬁelds of purinergic signaling. The
idea that the P2X receptor and channel may also be a
sensor is a very simple one. Its topology and that of the
ENaC superfamily is as much reminiscent of a growth
factor receptor as an ion channel. The P2X receptor
channel sensor may be one of many proteins that help the
cell Fsense_ its own external environment. The idea that the
P2X receptor is a cell surface zinc receptor might be more
difﬁcult to swallow. However, we predict that parallels and
crossover between extracellular ATP release and signaling
and extracellular zinc release and signaling will emerge in
multiple cell and tissue microenvironments in the coming
years.
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